Patents by Inventor Anthony J. Cutie

Anthony J. Cutie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Core formulation
    Patent number: 6403121
    Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: June 11, 2002
    Assignee: Aeropharm Technology Incorporated
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010046515
    Abstract: This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: November 29, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010036478
    Abstract: This invention relates to a controlled-release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: November 1, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation
    Publication number: 20010034374
    Abstract: This invention relates to a controlled release combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Application
    Filed: February 15, 2001
    Publication date: October 25, 2001
    Inventors: Akwete L. Adjei, Yaping Zhu, Anthony J. Cutie
  • Core formulation comprising troglitazone and abiguanide
    Patent number: 6296874
    Abstract: This invention relates to a combination drug product comprising troglitazone, e.g. its hydrochloride, and a biguamide, e.g. metformin. In particular, the product comprises a core of metformin, at least a portion thereof has a layer or coat thereon of troglitazone.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: October 2, 2001
    Assignee: Aeropharm Technology Incorporated
    Inventors: Anthony J. Cutie, Akwete L. Adjei
  • Medicinal aerosol formulation
    Patent number: 6261539
    Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a particulate drug, a propellant and a stabilizing agent comprising a water addition.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: July 17, 2001
    Inventors: Akwete Adjei, Anthony J. Cutie
  • Amino acid stabilized medical aerosol formulation
    Patent number: 6136294
    Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a particulate drug, a propellant and a stabilizing agent selected from an amino acid, an amino acid derivative and a mixture of the foregoing.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: October 24, 2000
    Assignee: Aeropharm Technology Inc.
    Inventors: Akwete Adjei, Anthony J. Cutie
  • Aerosol formulations containing a sugar as a dispersant
    Patent number: 6129905
    Abstract: Aerosol formulations for mucosal and/or topical administration containing one or more drugs and a sugar as a dispersant in a pharmaceutically acceptable propellant, are disclosed. Metered dose inhalers suitable for delivering such formulations are also disclosed.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: October 10, 2000
    Assignee: Aeropharm Technology, Inc.
    Inventor: Anthony J. Cutie
  • Environmentally safe flunisolide aerosol formulations for oral inhalation
    Patent number: 5891419
    Abstract: Aerosol formulations for oral inhalation containing flunisolide dispersed in HFC 134a and/or HFC 227 which are free of chlorofluorocarbons and surfactants, and contain little or no ethanol, are disclosed. Metered dose inhalers suitable for delivering such formulations are also disclosed.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: April 6, 1999
    Assignee: Aeropharm Technology Limited
    Inventor: Anthony J. Cutie
  • Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
    Patent number: 5891420
    Abstract: Aerosol formulations for oral inhalation containing triamcinolone acetonide and HFC 134a and/or HFC 227 as a propellant which are free of chlorofluorocarbons and surfactants are disclosed.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: April 6, 1999
    Assignee: Aeropharm Technology Limited
    Inventor: Anthony J. Cutie